Package 0074-2625-28

{"route": ["ORAL"], "spl_id": "2c392930-500d-4e9b-93ac-317c4d48251c", "openfda": {"nui": ["N0000182639", "N0000182638", "N0000185503", "N0000190113", "N0000190107", "N0000190108", "N0000190114", "N0000182138", "N0000191272", "N0000191256"], "unii": ["K6BUU8J72P", "2WU922TK3L"], "rxcui": ["1940703", "1940709", "2557906", "2557910"], "spl_set_id": ["7bf99777-0401-9095-8645-16c6e907fcc0"], "pharm_class_epc": ["Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]", "Hepatitis C Virus NS5A Inhibitor [EPC]"], "pharm_class_moa": ["HCV NS3/4A Protease Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]", "UGT1A1 Inhibitors [MoA]"], "manufacturer_name": ["AbbVie Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 CARTON in 1 CARTON (0074-2625-04)  / 7 BLISTER PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0074-2625-04", "marketing_start_date": "20250415"}, {"sample": false, "description": "4 CARTON in 1 CARTON (0074-2625-28)  / 7 DOSE PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 DOSE PACK", "package_ndc": "0074-2625-28", "marketing_start_date": "20170803"}, {"sample": false, "description": "2 CARTON in 1 CARTON (0074-2625-56)  / 4 CARTON in 1 CARTON / 7 DOSE PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 DOSE PACK", "package_ndc": "0074-2625-56", "marketing_start_date": "20170803"}, {"sample": false, "description": "84 TABLET, FILM COATED in 1 BOTTLE (0074-2625-84)", "package_ndc": "0074-2625-84", "marketing_start_date": "20210622"}], "brand_name": "Mavyret", "product_id": "0074-2625_2c392930-500d-4e9b-93ac-317c4d48251c", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "HCV NS3/4A Protease Inhibitors [MoA]", "Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]", "Hepatitis C Virus NS5A Inhibitor [EPC]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "UGT1A1 Inhibitors [MoA]", "UGT1A1 Inhibitors [MoA]"], "product_ndc": "0074-2625", "generic_name": "Glecaprevir and Pibrentasvir", "labeler_name": "AbbVie Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Mavyret", "active_ingredients": [{"name": "GLECAPREVIR", "strength": "100 mg/1"}, {"name": "PIBRENTASVIR", "strength": "40 mg/1"}], "application_number": "NDA209394", "marketing_category": "NDA", "marketing_start_date": "20170803", "listing_expiration_date": "20271231"}